Editorial for “Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments”
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.29018 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Debra E Horng. Beteiligte Einrichtung: Deb Horng Consulting LLC, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neuroprotective Agents, Multiple Sclerosis, Chronic Progressive. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Deb Horng Consulting LLC, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Debra E Horng
Zitieren
APA
Horng, D. E. (2024). Editorial for “Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments”. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29018
Vancouver
Horng DE. Editorial for “Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments”. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29018
BibTeX
@article{Horng2024,
author = {Horng, Debra E},
title = {Editorial for “Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments”},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.29018}
}
EUVIMED